Company CELLCEUTIX OTC Bulletin Board
Equities
CTIX
US15115V1017
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Feb. 01 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 07-06-19 |
Jane Harness
CTO | Chief Tech/Sci/R&D Officer | 55 | 16-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 07-06-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 6,692,473 | 0 | 2,358,537 ( 35.24 %) | 87.87 % |
Stock B | 1 | 522,529,811 | 465,030,028 ( 89.00 %) | 8,516,056 ( 1.630 %) |
Company contact information
Innovation Pharmaceuticals, Inc.
301 Edgewater Place Suite 100
01880, Wakefield
+
http://www.ipharminc.comSector
1st Jan change | Capi. | |
---|---|---|
-3.12% | 102B | |
+1.69% | 96.29B | |
+2.13% | 22.18B | |
-15.59% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.10% | 16.36B | |
+5.16% | 13.97B | |
+32.81% | 12.17B |
- Stock Market
- Equities
- IPIX Stock
- CTIX Stock
- Company CELLCEUTIX